|
41P Progression after chemo-IO and durvalumab in stage III non-small cell lung cancer (NSCLC): What should be the next line? Real-world study |
|
|
|
Titel: |
41P Progression after chemo-IO and durvalumab in stage III non-small cell lung cancer (NSCLC): What should be the next line? Real-world study |
Auteur: |
Shentzer Kutiel, T. Shamai, S. Waissengrin, B. Urban, D. Daher, S. Sorotzky, H. Wollner, M. Zer, A. Bar, J. Moskovitz, M. |
Verschenen in: |
Annals of oncology |
Paginering: |
Jaargang 33 () nr. S2 pagina's S51 |
Jaar: |
2022 |
Inhoud: |
|
Uitgever: |
European Society for Medical Oncology |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|